EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Sjogren’s Disease and Elevated Cardiovascular Risk: Mechanisms and Treatment

Jennifer Behbodikhah, Billy Ding, Belin Jacob, Nuzhat Batool, Elise Belilos, Joshua De Leon, Steven E Carsons, Allison B Reiss iD

Journal of Cardiovascular Development and Disease · 18.09.2025 · 12 (9) · 367

DOI: 10.3390/jcdd12090367 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 18.09.2025. Verfasst von Jennifer Behbodikhah und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, NYU Grossman Long Island School of Medicine, Mineola, NY 11501, USA. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 183 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autoimmune disorders are known to accelerate atherosclerosis, increasing the rate of cardiovascular disease. As the number one cause of morbidity and mortality in the general population, this risk is only enhanced in inflammatory conditions. Substantial evidence links increased cardiovascular disease to systemic lupus erythematosus and rheumatoid arthritis. However, Sjogren’s Disease (SjD) tends to follow a more indolent disease course, and its chronic inflammatory burden is often underrecognized. Pharmacologic agents are also limited and symptom management is often the mainstay of treatment. The majority of studies investigating cardiovascular disease in SjD show conflicting results. In this review, we shed some light on the association of SjD and cardiovascular disease. Furthermore, we also explore potential risk factors and mechanisms through which SjD may accelerate cardiovascular disease. We address the impact of standard CVD and SjD treatments on heart health and highlight clinically relevant tools for monitoring subclinical atherosclerosis in the SjD patient population.

Schlagwörter

Stichwörter der Autor:innen

Sjögren’s diseaseatherosclerosisautoimmune disordercardiovascular riskdyslipidemiatreatment

Autor:innen und Institutionen

  • Department of Medicine, NYU Grossman Long Island School of Medicine, Mineola, NY 11501, USA.
  • Department of Foundations of Medicine, NYU Grossman Long Island School of Medicine, Mineola, NY 11501, USA.

ORCID-Profile: Allison B Reiss

Zitieren

APA

Behbodikhah, J., Ding, B., Jacob, B., Batool, N., Belilos, E., De Leon, J., Carsons, S. E., & Reiss, A. B. (2025). Sjogren’s Disease and Elevated Cardiovascular Risk: Mechanisms and Treatment. Journal of Cardiovascular Development and Disease, 12(9), 367. https://doi.org/10.3390/jcdd12090367

Vancouver

Behbodikhah J, Ding B, Jacob B, Batool N, Belilos E, De Leon J, et al. Sjogren’s Disease and Elevated Cardiovascular Risk: Mechanisms and Treatment. Journal of Cardiovascular Development and Disease. 2025;12(9):367. doi:10.3390/jcdd12090367

BibTeX
@article{Behbodikhah2025,
  author = {Behbodikhah, Jennifer and Ding, Billy and Jacob, Belin and Batool, Nuzhat and Belilos, Elise and De Leon, Joshua and Carsons, Steven E and Reiss, Allison B},
  title = {Sjogren’s Disease and Elevated Cardiovascular Risk: Mechanisms and Treatment},
  journal = {Journal of Cardiovascular Development and Disease},
  year = {2025},
  volume = {12},
  number = {9},
  pages = {367},
  doi = {10.3390/jcdd12090367}
}
Kostenlos starten →